ES2337252T3 - Suspensiones liquidas farmaceuticas. - Google Patents

Suspensiones liquidas farmaceuticas. Download PDF

Info

Publication number
ES2337252T3
ES2337252T3 ES04013422T ES04013422T ES2337252T3 ES 2337252 T3 ES2337252 T3 ES 2337252T3 ES 04013422 T ES04013422 T ES 04013422T ES 04013422 T ES04013422 T ES 04013422T ES 2337252 T3 ES2337252 T3 ES 2337252T3
Authority
ES
Spain
Prior art keywords
particles
pfc
stable
liquid
suspended
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES04013422T
Other languages
English (en)
Spanish (es)
Inventor
Bruce Joseph Roser
Arcadio Garcia De Castro
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NOVA BIO PHARMA TECHNOLOGIES L
NOVA BIO-PHARMA TECHNOLOGIES Ltd
Original Assignee
NOVA BIO PHARMA TECHNOLOGIES L
NOVA BIO-PHARMA TECHNOLOGIES Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NOVA BIO PHARMA TECHNOLOGIES L, NOVA BIO-PHARMA TECHNOLOGIES Ltd filed Critical NOVA BIO PHARMA TECHNOLOGIES L
Application granted granted Critical
Publication of ES2337252T3 publication Critical patent/ES2337252T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ES04013422T 2000-10-13 2000-10-13 Suspensiones liquidas farmaceuticas. Expired - Lifetime ES2337252T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2000/028244 WO2002032402A1 (en) 2000-10-13 2000-10-13 Composition and method for stable injectable liquids

Publications (1)

Publication Number Publication Date
ES2337252T3 true ES2337252T3 (es) 2010-04-22

Family

ID=21741883

Family Applications (1)

Application Number Title Priority Date Filing Date
ES04013422T Expired - Lifetime ES2337252T3 (es) 2000-10-13 2000-10-13 Suspensiones liquidas farmaceuticas.

Country Status (12)

Country Link
EP (1) EP1328255A1 (xx)
JP (1) JP2004513093A (xx)
KR (1) KR20030096224A (xx)
CN (1) CN100339066C (xx)
AU (2) AU1198601A (xx)
CA (2) CA2424656C (xx)
ES (1) ES2337252T3 (xx)
MX (1) MXPA03003236A (xx)
NO (1) NO20031706D0 (xx)
PL (1) PL360052A1 (xx)
PT (1) PT1452171E (xx)
WO (1) WO2002032402A1 (xx)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2502825A1 (en) * 2002-10-22 2004-05-06 Dainippon Pharmaceutical Co., Ltd. Stabilized composition
JP2007001865A (ja) * 2003-09-16 2007-01-11 Ltt Bio-Pharma Co Ltd 脂溶性薬物封入微粒子、その製造法およびそれを含有する製剤
CA2562606A1 (en) 2004-04-13 2005-10-27 Cambridge Biostability Limited Liquids containing suspended glass particles
GB0408199D0 (en) * 2004-04-13 2004-05-19 Cambridge Biostability Ltd Liquids containing suspended sugar glass particles
GB2430880A (en) * 2005-10-04 2007-04-11 Cambridge Biostability Ltd Pharmaceutical compositions stabilized in glassy particles
GB0523638D0 (en) 2005-11-21 2005-12-28 Cambridge Biostability Ltd Pharmaceutical device for the administration of substances to patients
US8946200B2 (en) 2006-11-02 2015-02-03 Southwest Research Institute Pharmaceutically active nanosuspensions
WO2009091017A1 (ja) * 2008-01-18 2009-07-23 Asahi Kasei Pharma Corporation 安定な医薬組成物
US8404850B2 (en) 2008-03-13 2013-03-26 Southwest Research Institute Bis-quaternary pyridinium-aldoxime salts and treatment of exposure to cholinesterase inhibitors
US8722706B2 (en) 2008-08-15 2014-05-13 Southwest Research Institute Two phase bioactive formulations of bis-quaternary pyridinium oxime sulfonate salts
US8309134B2 (en) 2008-10-03 2012-11-13 Southwest Research Institute Modified calcium phosphate nanoparticle formation
WO2010146536A1 (en) 2009-06-18 2010-12-23 Koninklijke Philips Electronics N.V. Suspension of particles with drug
WO2011007327A2 (en) 2009-07-16 2011-01-20 Koninklijke Philips Electronics N.V. Suspension for therapeutic use and device for delivering said suspension
ES2362525B8 (es) 2009-10-08 2013-01-03 Azurebio, S.L. Formulación de medicamentos en forma de agujas percutaneas penetrantes.
US9028873B2 (en) 2010-02-08 2015-05-12 Southwest Research Institute Nanoparticles for drug delivery to the central nervous system
TWI654098B (zh) 2014-03-24 2019-03-21 日商精工愛普生股份有限公司 Belt printing device and tape printing system
RU2016141948A (ru) * 2014-03-27 2018-04-27 Новартис Аг Высушенные распылением дисперсии твердое-в-масле-в-воде активных фармацевтических ингредиентов для ингаляции

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR78151B (xx) * 1982-04-05 1984-09-26 Alcon Lab Inc
US5518731A (en) * 1990-09-27 1996-05-21 Allergan, Inc. Nonaqueous fluorinated drug delivery vehicle suspensions
AU3924193A (en) * 1992-03-19 1993-10-21 Allergan, Inc. Compositions comprising a drug delivery vehicle suspended in a nonaqueous fluorinated liquid
GB9705588D0 (en) * 1997-03-18 1997-05-07 Anglia Research Foundation Stable particle in liquid formulations
US6190701B1 (en) * 1999-03-17 2001-02-20 Peter M. Ronai Composition and method for stable injectable liquids

Also Published As

Publication number Publication date
CA2424656C (en) 2010-03-23
KR20030096224A (ko) 2003-12-24
CA2689856A1 (en) 2002-04-25
AU1198601A (en) 2002-04-29
PL360052A1 (en) 2004-09-06
CN100339066C (zh) 2007-09-26
PT1452171E (pt) 2010-03-08
NO20031706L (no) 2003-04-11
CA2689856C (en) 2013-09-24
CN1527699A (zh) 2004-09-08
AU2001211986B2 (en) 2007-04-26
NO20031706D0 (no) 2003-04-11
CA2424656A1 (en) 2002-04-25
EP1328255A1 (en) 2003-07-23
WO2002032402A1 (en) 2002-04-25
MXPA03003236A (es) 2004-12-03
JP2004513093A (ja) 2004-04-30

Similar Documents

Publication Publication Date Title
ES2337252T3 (es) Suspensiones liquidas farmaceuticas.
US6190701B1 (en) Composition and method for stable injectable liquids
AU2005232441B2 (en) Liquids containing suspended glass particles
EA001873B1 (ru) Стабильная частица в жидких композициях
AU2001211986A1 (en) Composition and method for stable injectable liquids
KR101399583B1 (ko) 생물학적 물질의 안정화 개선
CN113825529A (zh) 充气微泡
US20010055610A1 (en) Medicament administration system
EP1592443A1 (en) Improved anthrax vaccines and delivery methods
AU2005203369B2 (en) Pharmaceutical liquid suspensions
JP4027881B2 (ja) 安定注射液用の組成物および方法
JP4382706B2 (ja) 医薬液体懸濁物
EP1452171B1 (en) Pharmaceutical liquid suspensions
KR100743442B1 (ko) 약제적 액체 현탁액
RU2259817C2 (ru) Композиция для доставки стабильных инъецируемых жидкостей и способ доставки
ES2339783T3 (es) Liquidos que contienen particulas vitreas suspendidas.
NZ525026A (en) A two-component composition comprising particles of sugar glass and a biocompatible liquid perfluorocarbon
NZ538681A (en) A pharmaceutical composition comprising active biological ingredient carried by particles that form a stable suspension in a liquid indefinitely
ES2599629T3 (es) Una emulsión que contiene una sustancia medicinal no viva
RU2003113537A (ru) Композиция для доставки стабильных инъецируемых жидкостей и способ доставки
WO2012152707A1 (en) Microemulsions